Concepedia

Krystal A. Orlando

KA

6

Publications

328

Citations

6

H-Index

2012

Active since

Affiliations

University of British Columbia(Current)

Translational Genomics Research Institute

University of North Carolina at Chapel Hill

Canada's Michael Smith Genome Sciences Centre

BC Cancer Agency

Krystal A. Orlando is an author at University of British Columbia specializing in social sciences, neuropharmacology, and medicine.

ORCID

Top concepts

Publications per year

2012–2020

6

Publications

6

The histone methyltransferase <scp>EZH2</scp> is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

Yemin Wang, Shary Yuting Chen, Anthony N. Karnezis et al. · The Journal of Pathology · 2017 · 103 citations · Full text

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Yemin Wang, Shary Yuting Chen, Shane Colborne et al. · Molecular Cancer Therapeutics · 2018 · 74 citations · Full text

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Jessica D. Lang, William P.D. Hendricks, Krystal A. Orlando et al. · Clinical Cancer Research · 2018 · 68 citations · Full text

Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism

Krystal A. Orlando, Amber K Douglas, Aierken Abudu et al. · eLife · 2020 · 47 citations · Full text

Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression

Dennis E. Rhoads, Nicole Grimes, Sunaina Kaushal et al. · Pharmacology Biochemistry and Behavior · 2012 · 25 citations

, , +13

Rows per page

1–5 of 6